A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway.

Song JMin, Sung YMe, Nam JHan, Yoon H, Chung A, Moffat E, Jung M, Pak DTS, Kim J, Hoe H-S

J Alzheimers Dis. 2016; 51(2):591-604. PMID: 26890742. Abstract